Stage IV-S neuroblastoma. Results with definitive therapy
The results of management of 14 patients with Stage IV-S neuroblastoma are reported. The treatment policy, although not consistent over this time span, in general used a combination of radiotherapy and chemotherapy or infrequently one modality alone. Twelve of 14 (86%) survived more than 6 years. One patient, with a solitary mediastinal primary tumor, died of rapidly progressive disease at three months. The other death occurred in a 4.5-year-old presenting with hepatomegaly at diagnosis followed by skeletal dissemination 2.5 years later. Thirteen of the patients were younger than 1 year of age. Of the 11 patients that received radiotherapy, 4 experienced mild asymptomatic scoliosis or kyphoscoliosis at 3 to 12 years after initial therapy. A review of the literature indicates that spontaneous regression in this tumor is very frequent; therefore, it is recommended that for the common presentation of massive hepatomegaly in an infant, close observation is warranted, unless life threatening complications occur. However, initial therapeutic intervention may be indicated in those patients with life threatening presentations. This data did not substantiate the necessity for complete surgical excision of the primary tumor, as has been suggested by others.
- Research Organization:
- Mallinckrodt Institute of Radiology, St. Louis, Missouri
- OSTI ID:
- 6905113
- Journal Information:
- Cancer (Philadelphia); (United States), Vol. 53:10
- Country of Publication:
- United States
- Language:
- English
Similar Records
Skeletal sequelae of radiation therapy for malignant childhood tumors
Proton Radiotherapy for High-Risk Pediatric Neuroblastoma: Early Outcomes and Dose Comparison
Related Subjects
62 RADIOLOGY AND NUCLEAR MEDICINE
NEOPLASMS
RADIOTHERAPY
SIDE EFFECTS
AGE DEPENDENCE
CHEMOTHERAPY
PATIENTS
SURVIVAL TIME
DISEASES
MEDICINE
NUCLEAR MEDICINE
RADIOLOGY
THERAPY
560151* - Radiation Effects on Animals- Man
550603 - Medicine- External Radiation in Therapy- (1980-)